Development of cutaneous squamous cell carcinoma during pembrolizumab therapy. Mizutani K, Nakanishi T, Ikejiri M, Yuasa H, et al. J Dermatol 2020 Sep 17. doi: 10.1111/1346-8138.15614.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mizutani K, Nakanishi T, Ikejiri M, Yuasa H, et al. Development of cutaneous squamous cell carcinoma during pembrolizumab therapy. J Dermatol 2020 Sep 17. doi: 10.1111/1346-8138.15614.
PMID: 32940367